May, 2022 , Chemistry Today
CatSci's Senior Scientist, Dr Alice Dunbabin, participated in the latest Chemistry Today panel discussion on Catalysis.
April, 2022 , Chemistry Today
CatSci's Director of New Modalities, Dr Nigel Richardson, participated in the latest Chemistry Today panel discussion on Oligonucleotides.
March, 2022 , Molecule to Market
Our CEO, Dr Ross Burn discusses how pivoting in-line with the market's needs and having big aims of becoming an innovative medicines development partner led to business growth.
By: Ross Burn
December, 2021 , One Nucleus
Our Talent Lead and Equality and Diversity Champion, York discusses his career journey and offers valuable advice to early career seekers and shifters
By: Seb York
August, 2021 , Pharma Manufacturing
To achieve true sustainability, a more holistic approach to overall drug development is needed
By: Simon Tyler
June, 2021 , One Nucleus
Our Talent Lead, Seb York discusses how employers need to create an inclusive and supportive environment for their teams
June, 2021 , Pharma's Almanac
The broader suite of computer-aided synthesis planning tools is increasingly catching up with chemists in its ability to establish the most suitable way of putting together a target active pharmaceutical ingredient
By: Alan Steven
March, 2021 , The Medicine Maker
Technology transfer is full of risks. But risks can be mitigated with the right strategy and help from digital technologies
February, 2021 , The Medicine Maker
Speed and efficiency are everything in pharmaceutical synthesis – and that’s why biocatalysis is an increasingly attractive option
By: Alice Dunbabin
January, 2021 , The Small Molecule Manufacturer
Alan Steven explains why environmental sustainability and “big picture thinking” should be key considerations when selecting solvents for scale-up
